Lysophospholipid mediators in health and disease

K Kano, J Aoki, T Hla - Annual Review of Pathology …, 2022 - annualreviews.org
Lysophospholipids, exemplified by lysophosphatidic acid (LPA) and sphingosine 1-
phosphate (S1P), are produced by the metabolism and perturbation of biological …

Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer

MA Dacheux, DD Norman, GJ Tigyi, SC Lee - Pharmacology & therapeutics, 2023 - Elsevier
Lysophosphatidic acid (LPA) is a bioactive lipid mediator that regulates a variety of cellular
functions such as cell proliferation, migration, survival, calcium mobilization, cytoskeletal …

Pleotropic roles of autotaxin in the nervous system present opportunities for the development of novel therapeutics for neurological diseases

DR Herr, WS Chew, RL Satish, WY Ong - Molecular neurobiology, 2020 - Springer
Autotaxin (ATX) is a soluble extracellular enzyme that is abundant in mammalian plasma
and cerebrospinal fluid (CSF). It has two known enzymatic activities, acting as both a …

[HTML][HTML] Suppressing postcollection lysophosphatidic acid metabolism improves the precision of plasma LPA quantification

K Kano, H Matsumoto, N Kono, M Kurano… - Journal of Lipid …, 2021 - ASBMB
Lysophosphatidic acid (LPA) is a potent signaling lipid, and state-dependent alterations in
plasma LPA make it a promising diagnostic marker for various diseases. However, plasma …

Pathogenic mechanisms of lipid mediator lysophosphatidic acid in chronic pain

H Ueda - Progress in lipid research, 2021 - Elsevier
A number of membrane lipid-derived mediators play pivotal roles in the initiation,
maintenance, and regulation of various types of acute and chronic pain. Acute pain …

[HTML][HTML] Exosome-associated lysophosphatidic acid signaling contributes to cancer pain

IA Khasabova, SG Khasabov, M Johns, J Juliette… - Pain, 2023 - journals.lww.com
Pain associated with bone cancer remains poorly managed, and chemotherapeutic drugs
used to treat cancer usually increase pain. The discovery of dual-acting drugs that reduce …

[HTML][HTML] Development of an advanced liquid chromatography–tandem mass spectrometry measurement system for simultaneous sphingolipid analysis

B Uranbileg, E Sakai, M Kubota, H Isago, M Sumitani… - Scientific Reports, 2024 - nature.com
Mass spectrometry-based lipidomics approaches offer valuable tools for the detection and
quantification of various lipid species, including sphingolipids. The present study aimed to …

Spatial transcriptomics reveals unique molecular fingerprints of human nociceptors

D Tavares-Ferreira, S Shiers, PR Ray, A Wangzhou… - BiorXiv, 2021 - biorxiv.org
Nociceptors are specialized sensory neurons that detect damaging or potentially damaging
stimuli and are found in the dorsal root (DRG) and trigeminal ganglia. These neurons are …

TMEM120A/TACAN: A putative regulator of ion channels, mechanosensation, and lipid metabolism

M Gabrielle, T Rohacs - Channels, 2023 - Taylor & Francis
ABSTRACT TMEM120A (TACAN) is an enigmatic protein with several seemingly
unconnected functions. It was proposed to be an ion channel involved in sensing …

Lysophospholipids and their producing enzymes: Their pathological roles and potential as pathological biomarkers

S Yaginuma, J Omi, K Kano, J Aoki - Pharmacology & Therapeutics, 2023 - Elsevier
Accumulating evidence suggests that lysophospholipids (LPL) serve as lipid mediators that
exert their diverse pathophysiological functions via G protein-coupled receptors. These …